BridgeMD
New treatment option for Obstructive Sleep Apnea
Official title Comparative Assessment of Sleep Positive Airway Pressure Modalities (CASPAM)
ClinicalTrials.gov ID: NCT06564896
What this study is testing
- What it's testing
- Obstructive sleep apnea (OSA) has been one of the topmost global health problems. It is an underdiagnosed disease which have a huge burden on healthcare if left untreated.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged ≥ 18 years.
- Patients diagnosed with moderate to severe OSA (based on AHI classification from sleep study performed).
- Patients who are able to understand and answer the questionnaire given.
You likely can't join if
- Patients who are unable to give consent to the study.
- Patients who have been diagnosed with OSA and already on CPAP machine.
- Patients who had underlying Obesity Hypoventilation Syndrome (OHS).
- Patients who had underlying co-morbidities that worsen apnea symptoms, such as congestive cardiac failure, active malignancy, narcolepsy, active...
The study team makes the final eligibility decision.
Where it's taking place
- Cheras, Kuala Lumpur, Malaysia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cheras, Kuala Lumpur, Malaysia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.